New Age Alpha Advisors LLC Decreases Stock Position in Novanta Inc. $NOVT

New Age Alpha Advisors LLC lowered its stake in Novanta Inc. (NASDAQ:NOVT) by 64.8% during the 4th quarter, Holdings Channel reports. The firm owned 7,283 shares of the technology company’s stock after selling 13,425 shares during the quarter. New Age Alpha Advisors LLC’s holdings in Novanta were worth $867,000 at the end of the most recent reporting period.

Several other hedge funds have also bought and sold shares of the stock. Assetmark Inc. lifted its stake in Novanta by 22.4% in the 4th quarter. Assetmark Inc. now owns 541 shares of the technology company’s stock worth $64,000 after purchasing an additional 99 shares in the last quarter. Arizona State Retirement System lifted its stake in Novanta by 1.6% in the 3rd quarter. Arizona State Retirement System now owns 10,632 shares of the technology company’s stock worth $1,065,000 after purchasing an additional 171 shares in the last quarter. EverSource Wealth Advisors LLC raised its position in shares of Novanta by 120.1% during the 4th quarter. EverSource Wealth Advisors LLC now owns 427 shares of the technology company’s stock valued at $51,000 after buying an additional 233 shares in the last quarter. Van ECK Associates Corp raised its position in shares of Novanta by 17.2% during the 3rd quarter. Van ECK Associates Corp now owns 1,627 shares of the technology company’s stock valued at $163,000 after buying an additional 239 shares in the last quarter. Finally, Amundi raised its position in shares of Novanta by 1.4% during the 3rd quarter. Amundi now owns 18,287 shares of the technology company’s stock valued at $1,908,000 after buying an additional 245 shares in the last quarter. Hedge funds and other institutional investors own 98.35% of the company’s stock.

Novanta Stock Down 1.1%

Shares of NASDAQ NOVT opened at $161.51 on Thursday. The company has a current ratio of 3.56, a quick ratio of 2.69 and a debt-to-equity ratio of 0.15. Novanta Inc. has a 12-month low of $98.27 and a 12-month high of $165.56. The stock has a market capitalization of $5.75 billion, a price-to-earnings ratio of 117.04 and a beta of 1.62. The firm’s 50-day moving average price is $132.44 and its 200-day moving average price is $128.03.

Novanta (NASDAQ:NOVT) last posted its quarterly earnings data on Monday, May 11th. The technology company reported $0.81 earnings per share for the quarter, topping analysts’ consensus estimates of $0.78 by $0.03. Novanta had a net margin of 5.35% and a return on equity of 12.06%. The company had revenue of $257.71 million for the quarter, compared to analyst estimates of $253.40 million. During the same period in the prior year, the company posted $0.74 EPS. The firm’s revenue for the quarter was up 10.4% on a year-over-year basis. Novanta has set its FY 2026 guidance at 3.500-3.650 EPS and its Q2 2026 guidance at 0.810-0.860 EPS. On average, equities research analysts anticipate that Novanta Inc. will post 3.59 EPS for the current fiscal year.

Insider Transactions at Novanta

In related news, CFO Robert Buckley sold 9,957 shares of the stock in a transaction dated Monday, March 16th. The shares were sold at an average price of $116.77, for a total value of $1,162,678.89. Following the sale, the chief financial officer directly owned 96,616 shares of the company’s stock, valued at $11,281,850.32. This represents a 9.34% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CEO Matthijs Glastra sold 7,500 shares of the stock in a transaction dated Tuesday, May 12th. The stock was sold at an average price of $150.43, for a total transaction of $1,128,225.00. Following the completion of the sale, the chief executive officer directly owned 42,761 shares in the company, valued at $6,432,537.23. This trade represents a 14.92% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 23,957 shares of company stock worth $3,136,229 over the last three months. 1.20% of the stock is currently owned by corporate insiders.

Wall Street Analysts Forecast Growth

NOVT has been the topic of several recent research reports. Weiss Ratings restated a “hold (c-)” rating on shares of Novanta in a research report on Friday, April 17th. Wall Street Zen cut shares of Novanta from a “buy” rating to a “hold” rating in a research report on Saturday, April 18th. Finally, Robert W. Baird upped their target price on shares of Novanta from $144.00 to $173.00 and gave the company an “outperform” rating in a research report on Wednesday, May 13th. One research analyst has rated the stock with a Buy rating and two have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Hold” and a consensus target price of $173.00.

Novanta Profile

Novanta, Inc (NASDAQ: NOVT) is a global technology company that designs and manufactures precision components, subsystems and software used in advanced photonics and motion control applications. The company serves customers in the medical device and advanced industrial markets, supplying critical technologies for diagnostics and therapeutic systems, semiconductor and electronics manufacturing, and scientific instrumentation. Novanta’s product portfolio includes laser control modules, optics, beam delivery systems, high-precision motors, actuators, stages, and fluidics solutions designed to meet stringent accuracy and reliability requirements.

Novanta’s Photonics segment delivers laser and energy delivery components that enable minimally invasive surgical procedures and diagnostic imaging.